A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast Cancer

NCT01351597 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Breast Cancer
Metastatic Breast Cancer

Interventions

DRUG: docetaxel/ oxaliplatin

Sponsor

Korean Breast Cancer Study Group